Skip to content

2008 Press Releases

Dec 26, 2008

Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes  

Dec 26, 2008

Allergan Announces U.S. Food and Drug Administration (FDA) Approval of LATISSE™ -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes  

Dec 5, 2008

FDA Advisory Committee Unanimously Recommends Approval of LATISSE(TM) (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes  

Oct 29, 2008

Allergan Reports Third Quarter 2008 Operating Results  

Oct 29, 2008

Allergan, Inc. and Spectrum Pharmaceuticals, Inc. Announce Collaboration Agreement for Apaziquone (EOquin(R)  

Oct 15, 2008

Allergan, Inc. and Clinique Announce Nationwide Availability of CLINIQUE MEDICAL  

Oct 3, 2008

Allergan Announces Quarterly Conference Call  

Sep 11, 2008

Allergan Announces Positive Top-Line Results from Phase III BOTOX(R) Headache Program  

Jul 30, 2008

Allergan Reports Second Quarter 2008 Operating Results  

Jul 18, 2008

Validity of Allergan Patents Acknowledged by Jan Marini in Settlement of Allergan's Patent Infringement Suit Against Jan Marini Skin Research, Inc.  

Jul 15, 2008

Legendary Sports Icons, Nadia Comaneci and Mark Spitz, Support Your Personal Best Public Education Campaign  

Jul 14, 2008

Allergan Completes Acquisition of Aczone Gel 5%  

Jul 8, 2008

Allergan Announces Quarterly Conference Call  

Jun 16, 2008

Allergan Receives U.S. Food and Drug Administration Approval for TRIVARIS (triamcinolone acetonide injectable suspension) 80 mg/mL  

Jun 9, 2008

Allergan Announces Agreement to Acquire Aczone(R) Gel 5%  

Jun 4, 2008

Allergan Announces Intent to File New Drug Application for Bimatoprost as Novel Treatment to Stimulate Natural Eyelash Growth  

May 7, 2008

Allergan Reports First Quarter 2008 Operating Results  

May 1, 2008

Allergan Announces Research & Development Technology Review  

Apr 8, 2008

Allergan Announces Quarterly Conference Call  

Mar 3, 2008

Allergan Comments on the United States Department of Justice Subpoena for the Production of Documents Relating to Promotional Practices of BOTOX(R) for Therapeutic Uses  

Showing 1-20 of 27
Page: 1 2
 Next 20